Alternative Strategies for Development of Modified Release Dosage Forms
Read MoreWhat are examples of different modified-release dosage forms?
Explore some of the types of modified-release dosage forms that we can help you address. Have a specific question about a modified-release dosage form?
Gastro-retention
dosage forms
Includes swellable tablets (monolithic, bilayer, trilayer) that keep the formulation in the stomach for an extended period to maximize the duration of absorption or therapeutic activity
Gastro-resistant
dosage forms
Enteric-coated tablets or capsules that prevent release of the drug in the stomach and/or upper gastrointestinal (GI) tract.
Extended release
dosage forms
Matrix tablets, coated tablets, or multiparticulates that allow for extended or sustained release.
With extended-release dosage forms, we can adjust the in-vivo release profile of the drug, enabling once-daily dosing.
Pulsatile release
dosage forms
Pulsatile release dosage forms are beneficial for drugs where time-dependent dosing is required or those that undergo first-pass metabolism.
Biphasic release
dosage forms
Biphasic release dosage forms can give a rapid therapeutic effect from an immediate-release layer and extended dosing from a sustained-release layer, eliminating the need for repeat dosing.
Meet our modified release experts
We help transform your molecules into the medicines of the future. Our partnership is focused on a single goal: Delivering new treatments to those in need. Fast.
Meet some of the team members you’ll collaborate with on your project.
Dr. Andrew Lewis
Chief Scientific Officer
Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...
About AndrewDr. Asma Patel
VP, Integrated Development Services
Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...
About AsmaDr. Vanessa Zann
VP Scientific Consulting, TP-CP USA
Dr. Vanessa Zann is an VP Scientific Consulting, TP-CP USA at Quotient Sciences, with over twenty-five years industry experience p...
About VanessaJohn McDermott
Vice President, Scientific Consulting
John McDermott is Vice President of Scientific Consulting at Quotient Sciences. John leads Quotient Sciences' global drug developm...
About John